| Independent Non-Executive Director: | John LaMattina |
| Independent Non-Executive Director: | Michele Holcomb |
| Independent Non-Executive Director: | Kiran Mazumdar Shaw |
| Interim CEO: | Robert Lyne |
| Interim Chairman: | Sharon Barber-Lui |
| Non-Executive Dir: | Robert Langer, H. Robert Horvitz |
| Address: | 6 Tide St Ste 400, Boston, United States, MA, 02210 |
| Phone: | +1 617 482 2333 |
| Website: | http://www.puretechhealth.com |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE Small Cap, FTSE All-Share |
| Overseas Listings: | BATSLON:PRTCL |
| ISIN: | GB00BY2Z0H74 |
| Currency | UK Pounds |
| Share Price | 135.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 150.20 |
| 52 Week Low | 103.00 |
| Volume | 218,639 |
| Shares Issued | 241.68m |
| Market Cap | £326.27m |
| Beta | 0.55 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 13:49 | 10,999 @ 135.64p |
| 13:40 | 1 @ 135.60p |
| 13:34 | 2,160 @ 135.00p |
| 13:31 | 208 @ 135.00p |
| 13:31 | 3,560 @ 135.00p |
You are here: research